Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery
Key Takeaways
- Semaglutide can cause notable lean-mass loss, which threatens strength, metabolism, and long-term body composition.1
- A four-step framework with resistance training, targeted protein intake, a calorie floor with recovery support, and a lab-guided peptide upgrade addresses each mechanism of muscle loss.
- Resistance training 2–4 times weekly combined with 1.2–1.6 g protein per kg body weight daily provides the strongest evidence-based protection.1
- Recovery strategies such as creatine, adequate sleep, and micronutrient monitoring further safeguard lean mass during a caloric deficit.
- Book a consultation with Ellie Pranckevicius, FNP-BC at Mirror Plastic Surgery for a personalized, lab-guided muscle-preservation protocol.
4-Step Plan to Limit Muscle Loss on Semaglutide
The four steps below form a ranked, additive framework. Each step adds independent protection, and together they create the most defensible evidence-based approach available in 2026. Follow them in order and work with a qualified clinician to decide whether a medically supervised peptide upgrade belongs in your protocol.
- Perform resistance training 2–4 times weekly
- Hit 1.2–1.6 g protein per kg body weight daily
- Maintain a calorie floor and prioritize recovery
- Consider a medically supervised GLP-3R and GHRP upgrade
Step 1: Build a Simple Resistance-Training Routine
Semaglutide creates a sustained caloric deficit that drives skeletal muscle catabolism without a resistance-training stimulus, and adding that stimulus signals the body to shift composition toward fat-only loss. A 2026 ACSM position stand overview of reviews in Medicine & Science in Sports & Exercise recommends a pragmatic minimum of two to three resistance-training sessions per week targeting major muscle groups, with frequency scaled to individual tolerance.
Each session should cover the six foundational movement patterns:
- Squat or leg press
- Hip hinge (deadlift variation or hip thrust)
- Horizontal push (bench press or push-up)
- Horizontal pull (row variation)
- Vertical push (overhead press)
- Vertical pull (lat pulldown or pull-up)
Work 2–4 sets of 6–12 repetitions per movement and apply progressive overload, increasing weight, reps, or difficulty every one to two weeks as adaptation occurs. Walking, swimming, and yoga alone do not provide sufficient mechanical stimulus to preserve lean mass during a GLP-1-induced caloric deficit and must be paired with dedicated resistance work. Patients new to lifting should complete two to six supervised sessions to establish safe technique before adding load.
Step 2: Match Your Protein Intake to Your Goal
The LEAN-PREP randomized controlled trial protocol examines increased protein for lean-mass preservation during energy restriction. Distribution matters as much as total intake, and the LEAN-PREP protocol aims for even distribution of protein across the day to maximize muscle protein synthesis at each feeding.
A 2025 case series from Texas Tech University reported typical protein intakes of 1.6–2.3 g per kg of fat-free mass daily among patients who preserved lean soft tissue during GLP-1-induced weight loss. Many GLP-1 users still consume less protein than levels typically recommended for muscle preservation.
Increased protein intake works best for muscle mass preservation when combined with structured resistance training, so steps 1 and 2 function together rather than in isolation.
Step 3: Set a Calorie Floor and Support Recovery
A practical calorie floor of 1,500–1,800 kcal per day for most adults on semaglutide preserves the metabolic substrate needed for muscle repair without stalling fat loss. Aggressive restriction accelerates lean-mass catabolism and undermines the benefits of training and protein. The most defensible supportive care model for preserving lean mass during GLP-1-based obesity therapy combines food-first nutritional counseling, adequate protein intake, structured resistance exercise, management of gastrointestinal adverse effects, and risk-based monitoring of micronutrient inadequacy.
Recovery-focused additions with meaningful indirect evidence work together as a recovery cascade:
- Creatine monohydrate (3–5 g/day): Supports phosphocreatine resynthesis, training volume, and lean-mass retention during a caloric deficit, provided the body has enough energy and recovery time to rebuild.
- Sleep (7–9 hours): This is when that rebuilding occurs, and peak anabolic hormone secretion happens during slow-wave sleep, while chronic restriction elevates cortisol and accelerates muscle breakdown, which also blunts creatine’s impact.
- Micronutrient monitoring: Semaglutide-induced appetite suppression raises the risk of vitamin D, magnesium, and B12 insufficiency, and these deficits impair muscle function and weaken the recovery process that sleep and creatine support.
Creatine, essential amino acids or leucine, beta-hydroxy-beta-methylbutyrate, fiber, probiotics, omega-3 fatty acids, and multi-ingredient products remain adjunctive options supported mainly by indirect or phenotype-specific evidence, so they supplement rather than replace the first two steps.
Step 4: Use GLP-3R and GHRP Peptides When Labs Support It
Some patients optimize training and nutrition yet still experience disproportionate lean-mass loss, while others want a more comprehensive body-composition strategy from the outset. For these patients, Mirror Plastic Surgery offers a lab-guided peptide upgrade under Ellie Pranckevicius, FNP-BC.
The two primary additions to a semaglutide protocol are:
- GLP-3R compounding: A newer-generation GLP peptide reported to carry fewer gastrointestinal side effects than older GLP-1 formulations and a lower propensity for muscle wasting, while addressing insulin resistance, weight management, and cardiovascular risk factors.
- Sermorelin/Ipamorelin (GHRPs): Growth hormone-releasing peptides that stimulate natural growth hormone production, supporting muscle retention and recovery. Ipamorelin is selective for GH release with minimal cortisol or prolactin elevation, which makes it a well-tolerated adjunct to a weight-loss protocol.
No randomized trial has yet tested a growth hormone secretagogue plus GLP-1 agonist combination for body-composition outcomes as a primary endpoint, and the rationale for adding GHS peptides during semaglutide therapy remains mechanistic extrapolation from independent GH and GLP-1 literature, though some clinical practitioners report better body-composition outcomes anecdotally. Ellie’s protocols therefore rely on in-depth lab panels, including thyroid, liver, kidney, diabetes markers, and hormone panels, to ensure each addition fits your individual physiology.
Book an appointment with Ellie to review your labs and decide whether a GLP-3R or GHRP protocol belongs in your muscle-preservation plan.
Semaglutide vs. GLP-3R Stack: Muscle Retention Snapshot
The table below compares key body-composition metrics across three approaches. All figures are drawn from published sources, and where direct head-to-head data are unavailable, the distinction is noted.
| Metric | Semaglutide Alone | GLP-3R Stack + Lifestyle | Source |
|---|---|---|---|
| Absolute lean mass change | Notable reductions observed, with specific values varying across studies | Not yet established in RCT; GLP-3R reported to have lower muscle-wasting propensity than GLP-1 formulations (mechanistic extrapolation) | Various meta-analyses; Mirror Plastic Surgery clinical rationale |
| Lean mass % change at week 48 | Varies (BELIEVE trial, semaglutide 2.4 mg monotherapy) | Combination with activin receptor antibody reduced lean-mass change to −0.8% to −2.6% in the same trial (proxy for adjunctive muscle-sparing approach) | 2026 BELIEVE phase 2 trial, Nature Medicine |
| Proportion of weight loss from fat | Varies and often comes mostly from fat with proper support, though specific cohorts differ | Target of more than 80% fat with resistance training, protein, and GHRP support (clinical goal; no direct RCT)1 | Published cohorts; Mirror Plastic Surgery protocol objective |
| Monitoring protocol | BIA/DXA plus grip strength and gait speed every 3 months during year 1 | Same monitoring plus full hormone panel and liver, kidney, and thyroid labs at baseline and follow-up | DrOracle clinical guidance; Mirror Plastic Surgery concierge protocol |
Ellie Pranckevicius, FNP-BC: Your Peptide and Aesthetics Partner
Ellie Pranckevicius is the lead practitioner for peptide therapies and non-surgical aesthetics at Mirror Plastic Surgery. She holds a Bachelor’s in Health Science from Boston University, a Bachelor’s and Master’s in Nursing from the University of South Florida, and board certification as a Family Nurse Practitioner. Before entering advanced practice, Ellie spent four years in the Neuroscience ICU at Tampa General Hospital, a clinical environment that built deep fluency in metabolic physiology, hormonal regulation, and the body’s capacity for recovery under stress.

That ICU foundation directly shapes how she evaluates patients considering semaglutide, and she focuses on labs as well as symptoms. Ellie began her career at a high-end medical spa in Boston, where she developed expertise in skin physiology and aesthetic assessment before pursuing her NP credentials. This dual background of esthetician training plus advanced clinical medicine means she understands both the aesthetic outcomes patients want and the physiological levers required to achieve them safely.
Her approach to peptide oversight is educational and transparent, and she explains the mechanism behind every recommendation so patients understand not just what they are taking, but why. When a service or product is not yet necessary, she says so. At Mirror Plastic Surgery, Ellie’s peptide protocols are supported by Dr. Akash Chandawarkar, MD, a Harvard-educated physician, Johns Hopkins-trained plastic surgeon, and fellowship-trained aesthetic surgeon at Manhattan Eye Ear & Throat Hospital/Lenox Hill Hospital, which ensures that the full clinical depth of the practice stands behind every non-surgical protocol.
Book an appointment with Ellie and receive a concierge-level evaluation of your semaglutide protocol, including lab review and a personalized muscle-preservation plan.
Weekly Muscle-Preservation Checklist
Use the following checklist to audit your protocol each week and bring it to your Mirror Plastic Surgery consultation as a baseline reference.
Training
- 2–4 full-body resistance sessions completed
- All six movement patterns covered (squat, hinge, push, pull, vertical push, vertical pull)
- Progressive overload applied, with weight, reps, or difficulty increased versus the prior week
Nutrition
- Daily protein at or above 1.2 g/kg body weight, with a target of 1.6 g/kg
- At least 25 g protein per meal, distributed across 3–4 meals
- Total daily calories at or above 1,500 kcal
- Creatine monohydrate 3–5 g taken daily
Recovery
- 7–9 hours of sleep per night
- Gastrointestinal side effects managed, with nausea and reduced appetite addressed with your provider
Lab Markers to Monitor (with your clinician)
- Body composition via BIA or DXA every 3 months
- Grip strength assessment at baseline and follow-up
- Hormone panel including GH, IGF-1, and testosterone or estradiol
- Thyroid, liver, kidney, and diabetes markers
- Vitamin D, magnesium, and B12
Frequently Asked Questions
How much muscle can I expect to lose on semaglutide without any countermeasures?
Clinical data consistently show that somewhere between 25% and 40% of total weight lost on semaglutide can come from lean tissue when no specific countermeasures are in place.1 In absolute terms, the largest lean-mass losses observed in controlled trials have exceeded 5 kg over 48 weeks at the 2.4 mg dose.1 The proportion varies based on starting body composition, dose, rate of weight loss, and whether any resistance training or protein targeting is in place.1
Relative body composition, meaning the ratio of lean mass to fat mass, often improves even when absolute lean mass declines because fat loss is proportionally larger.1 Absolute lean-mass loss still matters for strength, metabolic rate, and long-term weight maintenance, which is why proactive countermeasures are warranted from the first week of therapy.
Are the GLP-3R and GHRP peptides Ellie uses FDA-approved?
As noted in Step 4, these peptides are not FDA-regulated in the same way as pharmaceutical drugs, though they are used extensively in clinical and research settings worldwide. The primary risk associated with peptides involves obtaining them from unregulated sources without medical supervision, where quality, purity, and dosing accuracy cannot be verified. At Mirror Plastic Surgery, Ellie sources all peptides from reputable compounding providers that undergo rigorous batch testing.
Every protocol begins with a comprehensive lab panel and medical history review to confirm that the selected peptides match your individual health profile. Patients receive detailed instructions, ongoing monitoring, and direct access to Ellie throughout their protocol.
Will I lose the muscle-preservation benefits if I stop the peptide protocol?
Benefits from any health intervention, whether pharmaceutical, peptide-based, or exercise-driven, diminish when the intervention is discontinued. If you stop Sermorelin or Ipamorelin, the stimulated growth hormone pulse returns to its baseline level over time.1 If you stop resistance training, the anabolic stimulus is removed and muscle mass gradually declines.1
Mirror Plastic Surgery therefore structures peptide protocols around long-term maintenance rather than short-term courses. Ellie works with each patient to determine an appropriate maintenance phase once initial goals are achieved, adjusting the protocol based on follow-up labs and body-composition reassessments.
How does Mirror Plastic Surgery monitor for excessive muscle loss during semaglutide therapy?
Ellie’s concierge protocol begins with a baseline assessment that includes a full hormone panel, thyroid, liver, kidney, and diabetes markers, and, where indicated, body composition measurement via BIA or DXA. Grip strength and functional assessments provide additional baseline data. Follow-up labs and body-composition checks are scheduled at approximately three-month intervals during the first year, then adjusted based on individual progress.
If lean-mass loss exceeds acceptable thresholds, the protocol is escalated by increasing resistance training frequency, adjusting protein targets, or modifying the peptide stack before considering any change to the semaglutide dose. This level of monitoring is not standard in high-volume weight-loss clinics and serves as a defining feature of Mirror Plastic Surgery’s concierge approach.
Can I do this protocol remotely if I am not in the Tampa Bay area?
Mirror Plastic Surgery’s peptide consultations and ongoing care can be conducted entirely via telemedicine, with peptides shipped directly to patients across the United States, including Hawaii and Alaska. The initial consultation with Ellie covers your medical history, current medications, and health goals. If lab results are not already available, Ellie will order the appropriate panels.
Once your protocol is established, you have direct text access to Ellie for questions, refill requests, and protocol adjustments, which replicates the concierge experience regardless of geography.
Conclusion: Protect Your Strength While Losing Fat
Semaglutide is a powerful fat-loss tool, yet lean-mass loss can occur with use of GLP-1 receptor agonists, which becomes a clinically meaningful concern for anyone over 40 who depends on muscle for metabolic health, strength, and quality of life. The four-step framework above, including resistance training 2–4 times weekly, 1.2–1.6 g/kg protein daily, a 1,500–1,800 kcal calorie floor with creatine and sleep, and a lab-guided GLP-3R/GHRP upgrade, addresses every major mechanism of semaglutide-induced muscle loss.
Steps 1 through 3 are evidence-based and accessible today, while Step 4 requires a qualified clinician who can read your labs, source verified peptides, and monitor your progress over time. Book an appointment with Ellie at Mirror Plastic Surgery in St. Petersburg, Florida, and receive a personalized, lab-guided muscle-preservation protocol built around your semaglutide journey.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.


